Skip to main content
Log in

Haloperidol decanoate more cost effective than paliperidone

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Rosenheck RA, et al. Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia. Psychiatric Services : 1 Jun 2016. Available from: URL: http://doi.org/10.1176/appi.ps.201500447

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haloperidol decanoate more cost effective than paliperidone. PharmacoEcon Outcomes News 755, 24 (2016). https://doi.org/10.1007/s40274-016-3131-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3131-0

Navigation